分析师提供有关医疗保健公司的见解:Apyx Medical(APYX)和Better Therapeutics, Inc.(BTTX)
Better Therapeutics, Inc.(BTTX)获得湖街的买入评级
LifeSci Capital 重申对Better Therapeutics, Inc.(BTTX)
LifeSci Capital坚持其对Better Therapeutics, Inc.(BTTX)的持仓
Lake Street维持对Better Therapeutics的买入,将目标股价
更好的治疗分析师评级
Chardan Capital重申买入Better Therapeutics,维持9美元的目标股价
更好的治疗分析师评级
Better Therapeutics, Inc. (BTTX) 获得 LifeSci Capital
LifeSci Capital 重申对Better Therapeutics, Inc.(BTTX)
Chardan Capital 仍在买入 Better Therapeutics, Inc.(BTTX)
湖街维持对Better Therapeutics的买入,将目标价下调至5美元
LifeSci Capital 仍持有 Better Therapeutics, Inc. (BT
Chardan Capital 维持对更好疗法的买入,将目标价下调至9美元
Chardan 将Better Therapeutics的目标股价从14美元下调至9美元,这反映了预计的股数稀释率增加,维持买入评级
分析师提供有关医疗保健公司的见解:Lantheus(LNTH)和Better Therapeutics, Inc.(BTTX)
Better Treeutics分析师评级
Chardan将Better Treateutics目标价从17美元下调至14美元,原因是预期股价稀释,重申买入评级
分析师提供有关医疗保健公司的见解:Achieve Life Sciences(ACHV)和Better Therapeutics, Inc.(B